These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations]. Mamolat AS; Bialik IB Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969 [No Abstract] [Full Text] [Related]
3. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests]. Pruszyńska S Gruzlica; 1971 Dec; 39(12):1211-8. PubMed ID: 5139240 [No Abstract] [Full Text] [Related]
4. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis. Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720 [No Abstract] [Full Text] [Related]
5. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs. Horsfall PA Tubercle; 1972 Sep; 53(3):166-73. PubMed ID: 4116994 [No Abstract] [Full Text] [Related]
6. [The four-fold treatment of serious forms of pulmonary tuberculosis]. Amsler R Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624 [No Abstract] [Full Text] [Related]
7. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis. Bignall JR; Lind A; Rist N Bull Int Union Tuberc; 1969 Aug; 42():7-57. PubMed ID: 5004884 [No Abstract] [Full Text] [Related]
8. Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy. Pneumonologie; 1975; 151(3):167-84. PubMed ID: 1187376 [No Abstract] [Full Text] [Related]
9. [Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults]. Sosnowski W; Kubiak Z Gruzlica; 1972 Jan; 40(1):21-8. PubMed ID: 5011722 [No Abstract] [Full Text] [Related]
10. [On qualitative demonstration of tuberculostatics in the control of taking of drugs]. Grunert M; Reutgen H; Iwainsky H Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136 [No Abstract] [Full Text] [Related]
11. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis]. Zanotelli F; Perusi O G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781 [No Abstract] [Full Text] [Related]
12. [Centrilobular parenchymal necrosis of the liver. A contribution to the knowledge of drug induced lesions of the liver (author's transl)]. Beckert W Zentralbl Allg Pathol; 1973; 117(3):219-26. PubMed ID: 4520112 [No Abstract] [Full Text] [Related]
13. [Side effects of ETA combined with INH and SM in the first antituberculous treatment of pulmonary tuberculosis]. Sosnowski W; Rozniecki J; Kubiak Z; Pruszyńska S Gruzlica; 1968 Oct; 36(10):983-5. PubMed ID: 5710105 [No Abstract] [Full Text] [Related]
14. [Association of ethionamide, isoniazid and ethambutol in the therapy of pulmonary tuberculosis]. Zanotelli F Fracastoro; 1967; 60(6):594-607. PubMed ID: 5617704 [No Abstract] [Full Text] [Related]
15. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol. Grymiński J; Lyczewska J; Styszewska H; Walczak J Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841 [No Abstract] [Full Text] [Related]
16. A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis. Devadatta S; Menon NK; Nazareth O; Radhakrishna S; Ramakrishnan CV; Somasundaram PR; Usha SP; Velu S Tubercle; 1970 Sep; 51(3):263-9. PubMed ID: 4924649 [No Abstract] [Full Text] [Related]
17. Pyrazinamide-isoniazid: its apparent influence on the reactivation rate in pulmonary tuberculosis. Phillips S Am Rev Respir Dis; 1967 Mar; 95(3):503-5. PubMed ID: 6066869 [No Abstract] [Full Text] [Related]
18. Cycloserine in the treatment of pulmonary tuberculosis. Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969 [No Abstract] [Full Text] [Related]
20. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2]. Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936 [No Abstract] [Full Text] [Related] [Next] [New Search]